Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)

被引:0
|
作者
Denerolle, P
Bourdoiseau, G
机构
[1] Ecole Vet Lyon, Dept Pathol & Clin Carnivores Domest, Parasitol Lab, F-69280 Marcy Etoile, France
[2] Clin Vet, Seyne Mer, France
关键词
dogs; Leishmania infantum; protozoal disease; therapy;
D O I
10.1892/0891-6640(1999)013<0413:CAAATV>2.3.CO;2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the present study was to evaluate the long-term clinical outcome for dogs with leishmaniasis that were treated with 3 different protocols: combined treatment with antimony and allopurinol, antimony alone, or allopurinol alone. Ninety-six dogs included in this study were determined to have leishmaniasis on the basis of (1) clinical features, (2) identification of the parasite in smears of lymph node, bone marrow aspirates, or skin biopsies, and (3) specific immunofluorescent assay. Three groups of dogs were defined: 45 dogs (group 1) were treated with antimony (100 mg/kg SC q24h) given concurrently for 1 month with allopurinol (15 mg/kg PO q12h), and then allopurinol alone for 8 months at the same dosage; 40 dogs (group 2) were treated with antimony alone according to the manufacturer's instructions (200 mg/kg SC q24h at 2-day intervals for 3-6 months); and 11 dogs (group 3) were treated with allopurinol alone (15 mg/kg PO q12h for 1-20 months). Information concerning signalment, history, physical examination findings, serologic testing and number of dogs becoming seronegative, outcome for each treated dog (clinical cure versus failure), and long-term survival were recorded. The numbers of the clinical cures versus failures were significantly different among the 3 groups (chi(2) = 17.77, P < .001), between groups 1 and 2 (chi(2) = 8.02, P < .01), between groups 2 and 3 (chi(2) = 11.00, P < .01), and between groups 1 and 3 (chi(2) = 16.52, P < .001). No significant difference between groups 1 and 2 was noted in the type of failure (relapse or death), serologic test results, and number of survival years (chi(2) = 2.79. P > .05). The results of the present study indicate that antimony in combination with allopurinol produces better results than antimony alone or allopurinol alone for the treatment of the canine leishmaniasis. With combination treatment, duration of treatment with antimony is shorter and long-term administration of allopurinol is well tolerated.
引用
收藏
页码:413 / 415
页数:3
相关论文
共 50 条
  • [31] Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS
    Kaplanski, G
    Buscaylet, S
    PenotRagon, C
    Durand, JM
    Soubeyrand, J
    AIDS, 1996, 10 (10) : 1172 - 1174
  • [32] Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum
    Farca, Anna Maria
    Miniscalco, B.
    Badino, P.
    Odore, R.
    Monticelli, P.
    Trisciuoglio, A.
    Ferroglio, E.
    PARASITOLOGY RESEARCH, 2012, 110 (06) : 2509 - 2513
  • [33] Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum
    Anna Maria Farca
    B. Miniscalco
    P. Badino
    R. Odore
    P. Monticelli
    A. Trisciuoglio
    E. Ferroglio
    Parasitology Research, 2012, 110 : 2509 - 2513
  • [34] Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran
    Goyonlo, Vahid Mashayekhi
    Derakhshan, Zahra
    Darchini-Maragheh, Emadodin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (06): : 1164 - 1166
  • [35] Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol
    Khodabandeh, Mahmoud
    Rostami, Ali
    Borhani, Katayoun
    Gamble, H. Ray
    Mohammadi, Mohsen
    PARASITOLOGY INTERNATIONAL, 2019, 72
  • [36] Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study
    Esfandiarpour, Iraj
    Dabiri, Shahriar H.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (08) : 848 - 852
  • [37] SUCCESSFUL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ALLOPURINOL AFTER FAILURE OF TREATMENT WITH KETOCONAZOLE
    BAUM, KF
    BERENS, RL
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) : 813 - 815
  • [38] Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis
    Boa Sorte Ayres, Eveline da Cruz
    de Lima Ruy Dias, Alvaro Felipe
    Gomes Monteiro, Bruna Ribeiro
    Pazzini, Sarah Szimanski
    Chagas Barbosa, Mateus Elias
    da Silva, Eveliny Barroso
    da Cruz Macedo, Luis Felipe
    Sousa, Valeria Regia Franco
    Dutra, Valeria
    Nakazato, Luciano
    Parto Ferreira de Almeida, Arleana do Bom
    REVISTA BRASILEIRA DE PARASITOLOGIA VETERINARIA, 2022, 31 (03):
  • [39] ANTIMONY ACCUMULATION IN HAIR DURING TREATMENT OF LEISHMANIASIS
    DOREA, JG
    COSTA, JML
    HOLZBECHER, J
    RYAN, DE
    MARSDEN, PD
    CLINICAL CHEMISTRY, 1987, 33 (11) : 2081 - 2082
  • [40] Antimony in the treatment of American leishmaniasis of the skin.
    Low, GC
    BRITISH MEDICAL JOURNAL, 1919, 1919 : 479 - 480